Policy
More in Policy
ASBMB expresses concerns about proposed NIH budget cuts
If passed, the appropriations bill would cut NIAID’s budget by almost 23%, NINDS’s budget by 5% and both NCI and NIGMS’s budgets by almost 3%.
Taking action at a state level
While the ASBMB advocates on your behalf at the federal level, many science policy issues pop up at the state level. Here’s how you can advocate within your local community, with our help.
ASBMB raises concerns about proposed NIH subaward policy
The society says the new policy, if adopted, will discourage collaboration and heighten administrative burden on scientists.
ASBMB responds to proposed NIH NSRA fixes
The society applauds removal of grades from the application, inclusion of applicant special circumstance statement and reviewer bias training.
Biochemists and molecular biologists meet with federal agencies
ASBMB members meet with NIH, NSF, USDA, DOE and more to discuss basic science funding and programs.
Scientists’ political donations reflect polarization in academia
This has implications for the public’s trust in science.
An ancient practice in need of modern-day support
More in Policy
'I hope that our actions show our members that we are doing our best to support them'
A Q&A with ASBMB Policy Manager Raechel McKinley on the organization’s national-level advocacy for LGBTQIA+ scientists, trainees and students.
State laws change the landscape for LGBTQIA+ scientists
New legislation in the past 16 months has banned gender affirming care for transgender teens, teaching children about sexual orientation and gender identity, and drag shows.
Meet the 2023 ASBMB Advocacy Training Program delegates
ASBMB announces a new cohort of 12 ASBMB Advocacy Training Program delegates who will learn about science policy and advocacy through this summer externship
ASBMB members meet with lawmakers on the Hill
In 48 meetings, scientists advocated for budget increases for NIH, NSF and DOE.
Researchers to advocate for fundamental science on Capitol Hill
Sixteen ASBMB researchers from 16 states to meet with U.S. senators and representatives on Capitol Hill to advocate for basic science research funding for NIH, NSF, DOE
Will new FDA rules help dial back expedited drugs?
Recent reforms could require companies to perform follow-up studies on drugs that received accelerated approval.
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.